Roche, Generic Firms Offer SMART-er Accutane Risk Management Plan
Executive Summary
Roche and generic manufacturers' "consensus proposal" for additional Accutane (isotretinoin) risk management strategies will include mandatory patient and physician registries
You may also be interested in...
SMART-er Isotretinoin Risk Management Program To Be Operated By Covance
Covance will develop and operate a single, enhanced risk management program for all four isotretinoin products
Accutane Scripts Would Be Limited To Approved Indication Under House Bill
Prescriptions for Roche's Accutane would be limited to the acne drug's approved indication under legislation introduced June 16 by Reps. Bart Stupak (D-Mich.) and Chris Smith (R-N.J.)
Accutane Scripts Would Be Limited To Approved Indication Under House Bill
Prescriptions for Roche's Accutane would be limited to the acne drug's approved indication under legislation introduced June 16 by Reps. Bart Stupak (D-Mich.) and Chris Smith (R-N.J.)